Chondrogenic potentials of human synovium-derived cells sorted by specific surface markers

Osteoarthritis and Cartilage

Volumn 21, Issue 1, 2013, Pages 190-199

  Chang, C B ^a,b   Han, S A ^a   Kim, E M ^a   Lee, S ^a   Seong, S C ^a   Lee, M C ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

CD105 and CD166; Chondrogenic potential; Surface marker; Synovium derived cell

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA1 INTEGRIN; BETA1 INTEGRIN; CD133 ANTIGEN; CELL SURFACE MARKER; COLLAGEN TYPE 2; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; GAG PROTEIN; HERMES ANTIGEN; THY 1 ANTIGEN;

AGED; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE MATRIX; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CELL SELECTION; CHONDROGENESIS; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE; KNEE OSTEOARTHRITIS; MALE; PRIORITY JOURNAL; SYNOVIOCYTE;

AGED; ANTIGENS, CD; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CHONDROGENESIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; MALE; OSTEOARTHRITIS, KNEE; SYNOVIAL MEMBRANE;

EID: 84871925846     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.10.005     Document Type: Article

References (34)

1. Bedi A., Feeley B.T., Williams R.J. Management of articular cartilage defects of the knee. J Bone Joint Surg Am 2010, 92:994-1009.
2. Ghivizzani S.C., Oligino T.J., Robbins P.D., Evans C.H. Cartilage injury and repair. Phys Med Rehabil Clin N Am 2000, 11:289-307. vi.
3. Simon T.M., Jackson D.W. Articular cartilage: injury pathways and treatment options. Sports Med Arthrosc 2006, 14:146-154.
4. Gomoll A.H., Farr J., Gillogly S.D., Kercher J., Minas T. Surgical management of articular cartilage defects of the knee. J Bone Joint Surg Am 2010, 92:2470-2490.
5. Robinson D., Nevo Z. Articular cartilage chondrocytes are more advantageous for generating hyaline-like cartilage than mesenchymal cells isolated from microfracture repairs. Cell Tissue Bank 2001, 2:23-30.
6. Nakasa T., Ochi M. Cell based therapy for articular cartilage injury. Clin Calcium 2011, 21:890-895.
7. Richardson S.M., Hoyland J.A., Mobasheri R., Csaki C., Shakibaei M., Mobasheri A. Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol 2010, 222:23-32.
8. Nelson L., Fairclough J., Archer C.W. Use of stem cells in the biological repair of articular cartilage. Expert Opin Biol Ther 2010, 10:43-55.
9. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
10. Williams J.T., Southerland S.S., Souza J., Calcutt A.F., Cartledge R.G. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999, 65:22-26.
11. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
12. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
13. De Bari C., Dell'Accio F., Tylzanowski P., Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942.
14. Hunziker E.B., Rosenberg L.C. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 1996, 78:721-733.
15. Bakker A.C., van de Loo F.A., van Beuningen H.M., Sime P., van Lent P.L., van der Kraan P.M., et al. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 2001, 9:128-136.
16. Sakaguchi Y., Sekiya I., Yagishita K., Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005, 52:2521-2529.
17. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
18. Barry F.P., Boynton R.E., Haynesworth S., Murphy J.M., Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999, 265:134-139.
19. Majumdar M.K., Banks V., Peluso D.P., Morris E.A. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 2000, 185:98-106.
20. Deschaseaux F., Charbord P. Human marrow stromal precursors are alpha 1 integrin subunit-positive. J Cell Physiol 2000, 184:319-325.
21. Barry F., Boynton R., Murphy M., Haynesworth S., Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 2001, 289:519-524.
22. Fickert S., Fiedler J., Brenner R.E. Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthritis Cartilage 2003, 11:790-800.
23. Arufe M.C., De la Fuente A., Fuentes-Boquete I., De Toro F.J., Blanco F.J. Differentiation of synovial CD-105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J Cell Biochem 2009, 108:145-155.
24. Arai F., Ohneda O., Miyamoto T., Zhang X.Q., Suda T. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 2002, 195:1549-1563.
25. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238:265-272.
26. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
27. Simmons P.J., Gronthos S., Zannettino A., Ohta S., Graves S. Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis. Prog Clin Biol Res 1994, 389:271-280.
28. Zhu H., Mitsuhashi N., Klein A., Barsky L.W., Weinberg K., Barr M.L., et al. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006, 24:928-935.
29. Kadiyala S., Young R.G., Thiede M.A., Bruder S.P. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997, 6:125-134.
30. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998, 4:415-428.
31. Yoo J.U., Barthel T.S., Nishimura K., Solchaga L., Caplan A.I., Goldberg V.M., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998, 80:1745-1757.
32. Bowen M.A., Patel D.D., Li X., Modrell B., Malacko A.R., Wang W.C., et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 1995, 181:2213-2220.
33. Nelissen J.M., Peters I.M., de Grooth B.G., van Kooyk Y., Figdor C.G. Dynamic regulation of activated leukocyte cell adhesion molecule-mediated homotypic cell adhesion through the actin cytoskeleton. Mol Biol Cell 2000, 11:2057-2068.
34. Bruder S.P., Ricalton N.S., Boynton R.E., Connolly T.J., Jaiswal N., Zaia J., et al. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 1998, 13:655-663.